This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In

It’s rare to get such a massive high-yielder that’s also positioning itself for long-term growth. Of course, shares of Pfizer (NYSE:PFE) have faced immense challenges in the years that followed its COVID era peak. And while some rockier days might still be up ahead, the company has a lot of promising innovations in the pipeline. ... This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In